Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling

Estimating Breast Cancer Survival by Molecular Subtype in the Absence of Screening and Adjuvant Treatment

(2018) Diego F. Munoz et al.   MEDICAL DECISION MAKING

The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update

(2018) Oguzhan Alagoz et al.   MEDICAL DECISION MAKING

Structure, Function, and Applications of the Georgetown–Einstein (GE) Breast Cancer Simulation Model

(2018) Clyde B. Schechter et al.   MEDICAL DECISION MAKING

Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia

(2018) Jeroen J. van den Broek et al.   MEDICAL DECISION MAKING

Whose Preferences Matter? A Patient-Centered Approach for Eliciting Treatment Goals

(2017) Nananda F. Col et al.   MEDICAL DECISION MAKING

A Bayesian Simulation Model for Breast Cancer Screening, Incidence, Treatment, and Mortality

(2017) Xuelin Huang et al.   MEDICAL DECISION MAKING

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies

(2016) Jeanne S. Mandelblatt et al.   ANNALS OF INTERNAL MEDICINE

The Contribution of Mammography Screening to Breast Cancer Incidence Trends in the United States: An Updated Age-Period-Cohort Model

(2015) R. E. Gangnon et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Models in the Development of Clinical Practice Guidelines

(2014) J. Dik F. Habbema et al.   ANNALS OF INTERNAL MEDICINE

Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case–control studies

(2014) Amy Trentham-Dietz et al.   BREAST CANCER RESEARCH AND TREATMENT

Trends of Postmenopausal Estrogen Plus Progestin Prevalence in the United States Between 1970 and 2010

(2014) Patricia I. Jewett et al.   OBSTETRICS AND GYNECOLOGY

Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

(2013) Jeanne S. Mandelblatt   ANNALS OF INTERNAL MEDICINE

Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor Status

(2013) Mark F. Munsell et al.   EPIDEMIOLOGIC REVIEWS

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

(2013)   LANCET

Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality

(2012) Yaojen Chang et al.   BREAST CANCER RESEARCH AND TREATMENT

A Sustained Decline in Postmenopausal Hormone Use

(2012) Brian L. Sprague et al.   OBSTETRICS AND GYNECOLOGY

Race-Specific Impact of Natural History, Mammography Screening, and Adjuvant Treatment on Breast Cancer Mortality Rates in the United States

(2011) N. T. van Ravesteyn et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Age-Period-Cohort Models in Cancer Surveillance Research: Ready for Prime Time?

(2011) P. S. Rosenberg et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Performance of First Mammography Examination in Women Younger Than 40 Years

(2010) Bonnie C. Yankaskas et al.   JNCI-Journal of the National Cancer Institute

Sustained lower rates of breast cancer in the United States

(2008) Kathleen A. Cronin et al.   BREAST CANCER RESEARCH AND TREATMENT

Can multi-model combination really enhance the prediction skill of probabilistic ensemble forecasts?

(2008) A. P. Weigel et al.   QUARTERLY JOURNAL OF THE ROYAL METEOROLOGICAL SOCIETY